ORBITA Study: 60 Second Insights
Published: 03 August 2018
-
Views:
9
-
Likes:
7
-
Views:
9
-
Likes:
7
-
Up Next -
Part 6 | Session 3 Darrel Francis
-
Part 6 | Session 4 Rasha Al-Lamee
-
Part 7 | Session 1 Gregg Stone
-
Part 7 | Session 2 Ajay Kirtane
-
Part 7 | Session 3 Darrel Francis
-
Part 7 | Session 4 Rasha Al-Lamee
-
Part 1 | Session 1 Gregg Stone Gregg W Stone
-
Part 1 | Session 2 Ajay Kirtane Ajay J Kirtane
-
Part 1 | Session 3 Darrel Francis Darrel P Francis
-
Part 1 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
Part 2 | Session 1 Gregg Stone Gregg W Stone
-
Part 2 | Session 2 Ajay Kirtane Ajay J Kirtane
-
Part 2 | Session 3 Darrel Francis Darrel P Francis
-
Part 2 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
Part 3 | Session 1 Gregg Stone Gregg W Stone
-
Part 3 | Session 2 Ajay Kirtane Ajay J Kirtane
-
Part 3 | Session 3 Darrel Francis Darrel P Francis
-
Part 3 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
Part 4 | Session 1 Gregg Stone Gregg W Stone
-
Part 4 | Session 2 Ajay Kirtane Ajay J Kirtane
-
Part 4 | Session 3 Darrel Francis Darrel P Francis
-
Part 4 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
Part 5 | Session 1 Gregg Stone Gregg W Stone
-
Part 5 | Session 2 Ajay Kirtane Ajay J Kirtane
-
Part 5 | Session 3 Darrel Francis Darrel P Francis
-
Part 5 | Session 4 Rasha Al-Lamee Rasha Al-Lamee
-
Part 6 | Session 1 Gregg Stone Gregg W Stone
Overview
A short series of 60-second insight videos on the ORBITA Study. Hear the expert views in under one minute!
More from this programme
Part 1
Can you describe the ORBITA study in your own words?
Part 2
Why do you think that ORBITA failed to show a significant improvement in exercise capacity post PCI?
Part 3
After the results of ORBITA should we stop stenting?
Part 4
What was the biggest weakness of ORBITA?
Part 5
What is the biggest strength of ORBITA?
Part 6
How has ORBITA affected your clinical practice?
Part 7
Is there a need for further studies?
Faculty Biographies
Ajay J Kirtane
Ajay J Kirtane is an Assistant Professor of Clinical Medicine at the Center for Interventional Vascular Therapy, Division of Cardiology, at Columbia University Medical Center (CUMC). He is a practising interventional cardiologist at New York Presbyterian Hospital/CUMC with an interest in coronary and peripheral intervention. Dr Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons. He completed clinical and research fellowships in cardiovascular disease and coronary and peripheral vascular intervention at Beth Israel Deaconess Medical Center/Harvard Medical School in Boston.
Honors & Awards
Columbia University Medical Center:
2009 Ewig Clinical Teaching Award (three-year funded award), Department of Medicine
2010 Daniel V. Kimberg Junior Faculty Teaching Award, Department of Medicine (given annually to a single recipient)
2011-present Selected to be a Firm Attending on the Neu Firm, Columbia…